190 related articles for article (PubMed ID: 24118322)
1. Improvement in the outcome of invasive fusariosis in the last decade.
Nucci M; Marr KA; Vehreschild MJ; de Souza CA; Velasco E; Cappellano P; Carlesse F; Queiroz-Telles F; Sheppard DC; Kindo A; Cesaro S; Hamerschlak N; Solza C; Heinz WJ; Schaller M; Atalla A; Arikan-Akdagli S; Bertz H; Galvão Castro C; Herbrecht R; Hoenigl M; Härter G; Hermansen NE; Josting A; Pagano L; Salles MJ; Mossad SB; Ogunc D; Pasqualotto AC; Araujo V; Troke PF; Lortholary O; Cornely OA; Anaissie E
Clin Microbiol Infect; 2014 Jun; 20(6):580-5. PubMed ID: 24118322
[TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of disseminated fusariosis in a febrile neutropenic patient with combined antifungal therapy of voriconazol plus amphotericin B deoxycholate].
Olivares R; Luppi M; Díaz MC
Rev Chilena Infectol; 2018 Aug; 35(4):448-452. PubMed ID: 30534934
[TBL] [Abstract][Full Text] [Related]
3. Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.
Horn DL; Freifeld AG; Schuster MG; Azie NE; Franks B; Kauffman CA
Mycoses; 2014 Nov; 57(11):652-8. PubMed ID: 24943384
[TBL] [Abstract][Full Text] [Related]
4. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B.
Efe İris N; Güvenç S; Özçelik T; Demirel A; Koçulu S; Çevik E; Arat M
Turk J Haematol; 2016 Dec; 33(4):363-364. PubMed ID: 27311328
[No Abstract] [Full Text] [Related]
6. Fusariosis.
Nucci F; Nouér SA; Capone D; Anaissie E; Nucci M
Semin Respir Crit Care Med; 2015 Oct; 36(5):706-14. PubMed ID: 26398537
[TBL] [Abstract][Full Text] [Related]
7. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group.
Herbrecht R; Patterson TF; Slavin MA; Marchetti O; Maertens J; Johnson EM; Schlamm HT; Donnelly JP; Pappas PG
Clin Infect Dis; 2015 Mar; 60(5):713-20. PubMed ID: 25414266
[TBL] [Abstract][Full Text] [Related]
8. Fusariosis in Mexico: A 10-year retrospective series.
Barragán-Reyes A; Jácome LEL; Perales-Martínez D; Nava-Ruiz A; Hernández MLG; Cornejo-Juárez P; Rincón-Zuno J; Camacho A; Cendejas RF; Guzmán JMF; Rivera-Martínez NE; Ontañón-Zurita D; Reséndiz-Sánchez J; Juárez-Hernández E; Aguilar-Zapata D
Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37944000
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.
Hoenigl M; Jenks JD; Egger M; Nucci M; Thompson GR
Mycopathologia; 2023 Dec; 188(6):973-981. PubMed ID: 37653167
[TBL] [Abstract][Full Text] [Related]
10. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study.
Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G
Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
[TBL] [Abstract][Full Text] [Related]
12. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases.
García-Ruiz JC; Olazábal I; Adán Pedroso RM; López-Soria L; Velasco-Benito V; Sánchez-Aparicio JA; Navajas A; Montejo M; Moragues MD
Rev Iberoam Micol; 2015; 32(3):190-6. PubMed ID: 25936697
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy of voriconazole and terbinafine for disseminated fusariosis: case report and literature review.
Inano S; Kimura M; Iida J; Arima N
J Infect Chemother; 2013 Dec; 19(6):1173-80. PubMed ID: 23564310
[TBL] [Abstract][Full Text] [Related]
15. The Use of FDG PET-CT Imaging for the Assessment of Early Antifungal Treatment Response in Disseminated Fusariosis.
Seban RD; Bonardel G; Guernou M; Lussato D; Queneau M
Clin Nucl Med; 2017 Jul; 42(7):569-570. PubMed ID: 28481795
[TBL] [Abstract][Full Text] [Related]
16. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection.
Nucci M; Anaissie EJ; Queiroz-Telles F; Martins CA; Trabasso P; Solza C; Mangini C; Simões BP; Colombo AL; Vaz J; Levy CE; Costa S; Moreira VA; Oliveira JS; Paraguay N; Duboc G; Voltarelli JC; Maiolino A; Pasquini R; Souza CA
Cancer; 2003 Jul; 98(2):315-9. PubMed ID: 12872351
[TBL] [Abstract][Full Text] [Related]
17. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
[TBL] [Abstract][Full Text] [Related]
18. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
19. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
Liu JY; Chen WT; Ko BS; Yao M; Hsueh PR; Hsiao CH; Kuo YM; Chen YC
Med Mycol; 2011 Nov; 49(8):872-8. PubMed ID: 21449694
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy.
Kim MS; Lee HM; Sung HS; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
Int J Dermatol; 2012 May; 51(5):621-3. PubMed ID: 21790547
[No Abstract] [Full Text] [Related]
[Next] [New Search]
